Parenteral Drugs (India) Ltd.

3.39 ▼0%

21 August 2023, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pdindia.com
Market Cap 10.11 Cr.
Enterprise Value(EV) 116.34 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -25.61 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 41.82 Trailing Twelve Months Ending 2022-03
Book Value / Share -278.81 Trailing Twelve Months Ending 2022-03
Price to Book Value -0.01 Calculated using Price: 3.39
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.98 Cr. 29,816,300 Shares
FaceValue 10
About Parenteral Drugs (India) Ltd.
Established in the year 1983, Parenteral Drugs has dedicated itself to the manufacturing of the best quality vital life saving drug at the lowest possible cost. Over the years, its path breaking innovation has led not only to lower costs but better quality as well because PDPL firmly believes that better quality dose not necessarily mean higher price, it can also be achieved by indigenous techniques and innovative technologies.

Parenteral Drugs (India) Ltd. Delivery

Delivered Qty
Traded Qty

No Deliveries found

Parenteral Drugs (India) Ltd. Performance

1 Day
1 Week
1 Month
3 Month
6 Month
1 Year
-29.23%
2 Year
-41.45%
5 Year
-57.14%
10 Year
-87.54%

Parenteral Drugs (India) Ltd. Fundamental Ratios

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -44.85 -23.61 -46.67 -152.43 0 0 0 0 0
Return on Capital Employed (%) -5.15 1.9 -2.29 -8.13 -6.91 -5.55 -35.07 -52.31 0
Return on Assets (%) -12.8 -5.44 -8.41 -12.6 -12.16 -13.17 -23.45 -26.72 -29.65

Parenteral Drugs (India) Ltd. Balance Sheet

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 246 202 127 325 -17 -136 -447 -561 -683 -824
Non Curr. Liab. 427 456 427 440 462 370 4 -26 -59 -91
Curr. Liab. 162 166 230 300 428 593 878 1,006 1,144 1,201
Minority Int. 1 1 1 1 0 0 0 0 0 0
Equity & Liab. 835 825 785 1,066 872 827 435 419 402 286
Non Curr. Assets 629 619 549 902 750 727 368 351 334 219
Curr. Assets 192 200 235 163 122 99 67 67 68 67
Misc. Exp. not W/O 14 5 1 1
Total Assets 835 825 785 1,066 872 827 435 419 402 286

Parenteral Drugs (India) Ltd. Profit and Loss

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 327 274 263 260 230 224 32 32 12 9
Other Income 0 61 1 2 6 2 1 0 0 0
Total Income 328 334 264 262 236 226 33 32 12 9
Total Expenditure -341 -350 -248 -296 -252 -225 -50 -47 -24 -24
PBIDT -14 -15 15 -34 -17 0 -16 -14 -12 -16
Interest -56 -60 -70 -70 -86 -98 -96 -110 -125 -106
Depreciation -23 -19 -31 -23 -25 -24 -69 -17 -17 -40
Taxation -15 1 19 10 10 10 33 28 33 33
Exceptional Items 47 0 -1 0 52
PAT -108 -45 -68 -117 -118 -112 -148 -114 -122 -76
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -108 -45 -68 -117 -118 -112 -148 -114 -122 -76
Adjusted EPS -42 -15 -23 -39 -40 -38 -50 -38 -41 -26

Parenteral Drugs (India) Ltd. Cash Flow

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 20 -168 -60 2 58 134 167 477 112 125
Cash Fr. Inv. -147 -18 33 3 -110 -1 -1 97 0 0
Cash Fr. Finan. 133 182 25 -10 54 -134 -167 -574 -112 -125
Net Change 5 -3 -2 -5 1 0 0 0 0 0
Cash & Cash Eqvt 13 11 8 3 5 0 0 0 0 0

Parenteral Drugs (India) Ltd. Shareholding Pattern

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 73.28 73.28 73.28 73.28 73.28 73.28 73.28 73.28 73.29
Public 26.72 26.72 26.72 26.72 26.72 26.72 26.72 26.72 26.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 94.51 94.51 94.51 94.51 94.51 94.50

Parenteral Drugs (India) Ltd. Announcements

Tue, 27 Feb 2024
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
Post-Facto Intimation of the Seventh Meeting of Committee of Creditors (CoC) of Parenteral Drugs (India) Ltd. the Corporate Debtor was held on Friday 16th February 2024 at 02:30 PM.
Tue, 23 Jan 2024
Corporate Insolvency Resolution Process (CIRP)-Public Announcement
Post-Facto Intimation of the publication of Form G of Parenteral Drugs (India) Ltd. the Corporate Debtor which was published on Sunday 21st January 2024
Sat, 20 Jan 2024
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
Post-Facto Intimation of the Sixth Meeting of Committee of Creditors (CoC) of Parenteral Drugs (India) Ltd. the Corporate Debtor was held on Friday 19th January 2024 at 12:00 Noon

Parenteral Drugs (India) Ltd. Technical Scans

No Scans Found

Parenteral Drugs (India) Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 379,622.78 1,570.50 -0.7%
Cipla Ltd. 120,180.38 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. 107,577.80 6,420.70 -0.4%
Zydus Lifesciences Ltd. 95,400.24 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. 95,163.88 6,371.85 -3.7%
Divi's Laboratories Ltd. 93,921.46 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. 88,823.31 2,598.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.62 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 32.41 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.58 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 120.56 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 67.91 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.45 2,598.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.08 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 4.64 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.09 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 7.21 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.42 2,598.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,598.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,598.00 -1.0%

Parenteral Drugs (India) Ltd. FAQ's

What is Parenteral Drugs share price?

Can I buy Parenteral Drugs shares now?

What is the Market Cap of Parenteral Drugs?

What is the 52 Week High and Low of Parenteral Drugs?